Yun H - Search Results

1

Intravital imaging and single cell transcriptomic analysis for engraftment of mesenchymal stem cells in an animal model of interstitial cystitis/bladder pain syndrome.

Yu HY, Lee S, Ju H, Kim Y, Shin JH, Yun H, Ryu CM, Heo J, Lim J, Song S, Lee S, Hong KS, Chung HM, Kim JK, Choo MS, Shin DM. Yu HY, et al. Among authors: yun h. Biomaterials. 2022 Jan;280:121277. doi: 10.1016/j.biomaterials.2021.121277. Epub 2021 Nov 27. Biomaterials. 2022. PMID: 34861510 Free article. Review.

2

Induction of detrusor underactivity by extensive vascular endothelial damages of iliac arteries in a rat model and its pathophysiology in the genetic levels.

Kim M, Yu HY, Ju H, Shin JH, Kim A, Lee J, Ryu CM, Yun H, Lee S, Lim J, Heo J, Shin DM, Choo MS. Kim M, et al. Among authors: yun h. Sci Rep. 2019 Nov 8;9(1):16328. doi: 10.1038/s41598-019-52811-4. Sci Rep. 2019. PMID: 31705030 Free PMC article.

3

Glutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway.

Lim J, Heo J, Ju H, Shin JW, Kim Y, Lee S, Yu HY, Ryu CM, Yun H, Song S, Hong KS, Chung HM, Kim HR, Roe JS, Choi K, Kim IG, Jeong EM, Shin DM. Lim J, et al. Among authors: yun h. Sci Adv. 2020 Apr 15;6(16):eaba1334. doi: 10.1126/sciadv.aba1334. eCollection 2020 Apr. Sci Adv. 2020. PMID: 32490200 Free PMC article.

4

A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia.

Yu HY, Shin JH, Yun H, Ryu CM, Lee S, Heo J, Lim J, Park J, Hong KS, Chung HM, Shin DM, Choo MS. Yu HY, et al. Among authors: yun h. Stem Cell Rev Rep. 2021 Dec;17(6):2139-2152. doi: 10.1007/s12015-021-10204-z. Epub 2021 Jun 29. Stem Cell Rev Rep. 2021. PMID: 34189670 Free PMC article.

5

Small-sized mesenchymal stem cells with high glutathione dynamics show improved therapeutic potency in graft-versus-host disease.

Lim J, Heo J, Yu HY, Yun H, Lee S, Ju H, Nam YJ, Jeong SM, Lee J, Cho YS, Choo MS, Jeong EM, Ryu CM, Shin DM. Lim J, et al. Among authors: yun h. Clin Transl Med. 2021 Jul;11(7):e476. doi: 10.1002/ctm2.476. Clin Transl Med. 2021. PMID: 34323414 Free PMC article. No abstract available.

6

The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.

Heo J, Lee J, Nam YJ, Kim Y, Yun H, Lee S, Ju H, Ryu CM, Jeong SM, Lee J, Lim J, Cho YM, Jeong EM, Hong B, Son J, Shin DM. Heo J, et al. Among authors: yun h. Exp Mol Med. 2022 Jun;54(6):801-811. doi: 10.1038/s12276-022-00786-0. Epub 2022 Jun 21. Exp Mol Med. 2022. PMID: 35729325 Free PMC article.

7

Activating transcription factor-2 supports the antioxidant capacity and ability of human mesenchymal stem cells to prevent asthmatic airway inflammation.

Ju H, Yun H, Kim Y, Nam YJ, Lee S, Lee J, Jeong SM, Heo J, Kwon H, Cho YS, Jeong G, Ryu CM, Shin DM. Ju H, et al. Among authors: yun h. Exp Mol Med. 2023 Feb;55(2):413-425. doi: 10.1038/s12276-023-00943-z. Epub 2023 Feb 10. Exp Mol Med. 2023. PMID: 36765266 Free PMC article.

8

Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer.

Kim Y, Ju H, Yoo SY, Jeong J, Heo J, Lee S, Park JM, Yoon SY, Jeong SU, Lee J, Yun H, Ryu CM, Lee J, Nam YJ, Kwon H, Son J, Jeong G, Oh JH, Sung CO, Jeong EM, An J, Won S, Hong B, Lee JL, Cho YM, Shin DM. Kim Y, et al. Among authors: yun h. Cell Rep Med. 2023 Oct 17;4(10):101224. doi: 10.1016/j.xcrm.2023.101224. Epub 2023 Oct 4. Cell Rep Med. 2023. PMID: 37797616 Free PMC article.

9

Assessment of the Therapeutic Effectiveness of Glutathione-Enhanced Mesenchymal Stem Cells in Rat Models of Chronic Bladder Ischemia-Induced Overactive Bladder and Detrusor Underactivity.

Shin JH, Yu HY, Kwon H, Yun HD, Ryu CM, Shin DM, Choo MS. Shin JH, et al. Among authors: yun hd. Int J Stem Cells. 2024 Apr 18. doi: 10.15283/ijsc23147. Online ahead of print. Int J Stem Cells. 2024. PMID: 38631809 Free article.

10

Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.

Kim SY, Kim JH, Kim TY, Park SR, Yoon S, Lee S, Lee SH, Kim TM, Han SW, Kim HR, Yun H, Lee S, Kim J, Choi YL, Choi KS, Chae H, Ryu H, Lee GW, Zang DY, Ahn JB. Kim SY, et al. Among authors: yun h. BMC Cancer. 2024 May 9;24(1):574. doi: 10.1186/s12885-024-12338-y. BMC Cancer. 2024. PMID: 38724991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,709 results

Search Page